Furthermore, the addition of an OCCD biomarker panel effectively detects dysplasia and neoplasia: the collected cells are tested for atypia (suggestive of inflammation or dysplasia) and p53 (the most prevalent biomarker for malignant transformation in Barrett's oesophagus)11,12. Here, TP53 is linked to dysplasia.